急性冠症候群（ACS）の世界市場：市場規模・現状・予測

• 英文タイトル：Global Acute Coronary Syndrome (ACS) Market Size, Status and Forecast 2019-2025

• レポートコード：QYR9ST05225 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、93ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Enterprise License	￥1,154,400 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

※当調査レポートでは、急性冠症候群（ACS）の世界市場について調査・分析し、急性冠症候群（ACS）の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（単独療法、併用療法）、用途別（病院、外来手術センター、診断センター）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の急性冠症候群（ACS）市場動向 ・主要企業別マーケットシェア ・急性冠症候群（ACS）の種類別市場規模2014-2019 （単独療法、併用療法） ・急性冠症候群（ACS）の用途別市場規模2014-2019 （病院、外来手術センター、診断センター） ・急性冠症候群（ACS）の北米市場：主要企業・種類別/用途別市場規模 ・急性冠症候群（ACS）のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・急性冠症候群（ACS）の中国市場：主要企業・種類別/用途別市場規模 ・急性冠症候群（ACS）の日本国内市場：主要企業・種類別/用途別市場規模 ・急性冠症候群（ACS）の東南アジア市場：主要企業・種類別/用途別市場規模 ・急性冠症候群（ACS）のインド市場：主要企業・種類別/用途別市場規模 ・急性冠症候群（ACS）の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （Dexa Medica、GlaxoSmithKline、Novartis、Pfizer、Sanofi、Serum Institute of India、Biogen Inc、Eli Lilly and Company） ・急性冠症候群（ACS）の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ...

Acute coronary syndrome (ACS) is a syndrome (set of signs and symptoms) due to decreased blood flow in the coronary arteries such that part of the heart muscle is unable to function properly or dies. The most common symptom is chest pain, often radiating to the left shoulder or angle of the jaw, crushing, central and associated with nausea and sweating. Many people with acute coronary syndromes present with symptoms other than chest pain, particularly, women, older patients, and patients with diabetes mellitus.Increase in geriatric population and rise in the incidence of cardiac disorders are the major factors that drive the market growth. However, stringent government regulations for the approval of drugs are expected to restrain the market growth. Improvement in healthcare facilities in emerging regions such as Asia-Pacific and LAMEA are expected to provide new growth opportunities for the market during the analysis period.
In 2018, the global Acute Coronary Syndrome (ACS) market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Acute Coronary Syndrome (ACS) status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Acute Coronary Syndrome (ACS) development in United States, Europe and China.

The key players covered in this study
Dexa Medica
GlaxoSmithKline
Novartis
Pfizer
Sanofi
Serum Institute of India
Biogen Inc
Eli Lilly and Company

Market segment by Type, the product can be split into
Monotherapy
Combination Therapy

Market segment by Application, split into
Hospitals
Ambulatory Surgical Center
Diagnostic Centers

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Acute Coronary Syndrome (ACS) status, future forecast, growth opportunity, key market and key players.
To present the Acute Coronary Syndrome (ACS) development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Acute Coronary Syndrome (ACS) are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

---

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Acute Coronary Syndrome (ACS) Market Size Growth Rate by Type (2014-2025)
1.4.2 Monotherapy
1.4.3 Combination Therapy
1.5 Market by Application
1.5.1 Global Acute Coronary Syndrome (ACS) Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Ambulatory Surgical Center
1.5.4 Diagnostic Centers
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Acute Coronary Syndrome (ACS) Market Size
2.2 Acute Coronary Syndrome (ACS) Growth Trends by Regions
2.2.1 Acute Coronary Syndrome (ACS) Market Size by Regions (2014-2025)
2.2.2 Acute Coronary Syndrome (ACS) Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Acute Coronary Syndrome (ACS) Market Size by Manufacturers
3.1.1 Global Acute Coronary Syndrome (ACS) Revenue by Manufacturers (2014-2019)
3.1.2 Global Acute Coronary Syndrome (ACS) Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Acute Coronary Syndrome (ACS) Market Concentration Ratio (CR5 and HHI)
3.2 Acute Coronary Syndrome (ACS) Key Players Head office and Area Served
3.3 Key Players Acute Coronary Syndrome (ACS) Product/Solution/Service
3.4 Date of Enter into Acute Coronary Syndrome (ACS) Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Acute Coronary Syndrome (ACS) Market Size by Type (2014-2019)
4.2 Global Acute Coronary Syndrome (ACS) Market Size by Application (2014-2019)

5 United States
5.1 United States Acute Coronary Syndrome (ACS) Market Size (2014-2019)
5.2 Acute Coronary Syndrome (ACS) Key Players in United States
5.3 United States Acute Coronary Syndrome (ACS) Market Size by Type
5.4 United States Acute Coronary Syndrome (ACS) Market Size by Application

6 Europe
6.1 Europe Acute Coronary Syndrome (ACS) Market Size (2014-2019)
6.2 Acute Coronary Syndrome (ACS) Key Players in Europe
6.3 Europe Acute Coronary Syndrome (ACS) Market Size by Type
6.4 Europe Acute Coronary Syndrome (ACS) Market Size by Application

7 China
7.1 China Acute Coronary Syndrome (ACS) Market Size (2014-2019)
7.2 Acute Coronary Syndrome (ACS) Key Players in China
7.3 China Acute Coronary Syndrome (ACS) Market Size by Type
7.4 China Acute Coronary Syndrome (ACS) Market Size by Application

8 Japan
8.1 Japan Acute Coronary Syndrome (ACS) Market Size (2014-2019)
8.2 Acute Coronary Syndrome (ACS) Key Players in Japan
8.3 Japan Acute Coronary Syndrome (ACS) Market Size by Type
8.4 Japan Acute Coronary Syndrome (ACS) Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Acute Coronary Syndrome (ACS) Market Size (2014-2019)
9.2 Acute Coronary Syndrome (ACS) Key Players in Southeast Asia
9.3 Southeast Asia Acute Coronary Syndrome (ACS) Market Size by Type
9.4 Southeast Asia Acute Coronary Syndrome (ACS) Market Size by Application

10 India
10.1 India Acute Coronary Syndrome (ACS) Market Size (2014-2019)
10.2 Acute Coronary Syndrome (ACS) Key Players in India
10.3 India Acute Coronary Syndrome (ACS) Market Size by Type
10.4 India Acute Coronary Syndrome (ACS) Market Size by Application

11 Central & South America
11.1 Central & South America Acute Coronary Syndrome (ACS) Market Size (2014-2019)
11.2 Acute Coronary Syndrome (ACS) Key Players in Central & South America
11.3 Central & South America Acute Coronary Syndrome (ACS) Market Size by Type
11.4 Central & South America Acute Coronary Syndrome (ACS) Market Size by Application

12 International Players Profiles
12.1 Dexa Medica
12.1.1 Dexa Medica Company Details
12.1.2 Company Description and Business Overview
12.1.3 Acute Coronary Syndrome (ACS) Introduction
12.1.4 Dexa Medica Revenue in Acute Coronary Syndrome (ACS) Business (2014-2019)
12.1.5 Dexa Medica Recent Development
12.2 GlaxoSmithKline
12.2.1 GlaxoSmithKline Company Details
12.2.2 Company Description and Business Overview
12.2.3 Acute Coronary Syndrome (ACS) Introduction
12.2.4 GlaxoSmithKline Revenue in Acute Coronary Syndrome (ACS) Business (2014-2019)
12.2.5 GlaxoSmithKline Recent Development
12.3 Novartis
12.3.1 Novartis Company Details
12.3.2 Company Description and Business Overview
12.3.3 Acute Coronary Syndrome (ACS) Introduction
12.3.4 Novartis Revenue in Acute Coronary Syndrome (ACS) Business (2014-2019)
12.3.5 Novartis Recent Development
12.4 Pfizer
12.4.1 Pfizer Company Details
12.4.2 Company Description and Business Overview
12.4.3 Acute Coronary Syndrome (ACS) Introduction
12.4.4 Pfizer Revenue in Acute Coronary Syndrome (ACS) Business (2014-2019)
12.4.5 Pfizer Recent Development
12.5 Sanofi
12.5.1 Sanofi Company Details
12.5.2 Company Description and Business Overview
12.5.3 Acute Coronary Syndrome (ACS) Introduction
12.5.4 Sanofi Revenue in Acute Coronary Syndrome (ACS) Business (2014-2019)
12.5.5 Sanofi Recent Development
12.6 Serum Institute of India
12.6.1 Serum Institute of India Company Details
12.6.2 Company Description and Business Overview
12.6.3 Acute Coronary Syndrome (ACS) Introduction
12.6.4 Serum Institute of India Revenue in Acute Coronary Syndrome (ACS) Business (2014-2019)
12.6.5 Serum Institute of India Recent Development
12.7 Biogen Inc
12.7.1 Biogen Inc Company Details
12.7.2 Company Description and Business Overview
12.7.3 Acute Coronary Syndrome (ACS) Introduction
12.7.4 Biogen Inc Revenue in Acute Coronary Syndrome (ACS) Business (2014-2019)
12.7.5 Biogen Inc Recent Development
12.8 Eli Lilly and Company
12.8.1 Eli Lilly and Company Company Details
12.8.2 Company Description and Business Overview
12.8.3 Acute Coronary Syndrome (ACS) Introduction
12.8.4 Eli Lilly and Company Revenue in Acute Coronary Syndrome (ACS) Business (2014-2019)
12.8.5 Eli Lilly and Company Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Acute Coronary Syndrome (ACS) Key Market Segments
Table Key Players Acute Coronary Syndrome (ACS) Covered
Table Global Acute Coronary Syndrome (ACS) Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Acute Coronary Syndrome (ACS) Market Size Market Share by Type 2014-2025
Figure Monotherapy Figures
Table Key Players of Monotherapy
Figure Combination Therapy Figures
Table Key Players of Combination Therapy
Table Global Acute Coronary Syndrome (ACS) Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospitals Case Studies
Figure Ambulatory Surgical Center Case Studies
Figure Diagnostic Centers Case Studies
Figure Acute Coronary Syndrome (ACS) Report Years Considered
Table Global Acute Coronary Syndrome (ACS) Market Size 2014-2025 (Million US$)
Figure Global Acute Coronary Syndrome (ACS) Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Acute Coronary Syndrome (ACS) Market Size by Regions 2014-2025 (Million US$)
Table Global Acute Coronary Syndrome (ACS) Market Size by Regions 2014-2019 (Million US$)
Table Global Acute Coronary Syndrome (ACS) Market Share by Regions 2014-2019
Figure Global Acute Coronary Syndrome (ACS) Market Share by Regions 2014-2019
Figure Global Acute Coronary Syndrome (ACS) Market Share by Regions 2019
Table Market Top Trends
Table Global Acute Coronary Syndrome (ACS) Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Acute Coronary Syndrome (ACS) Market Share by Manufacturers (2014-2019)
Figure Global Acute Coronary Syndrome (ACS) Market Share by Manufacturers in 2018
Table Global Acute Coronary Syndrome (ACS) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Acute Coronary Syndrome (ACS) Product/Solution/Service
Table Date of Enter into Acute Coronary Syndrome (ACS) Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Acute Coronary Syndrome (ACS) Market Size by Type (2014-2019) (Million US$)
Table Global Acute Coronary Syndrome (ACS) Market Size Share by Type (2014-2019)
Figure Global Acute Coronary Syndrome (ACS) Market Size Market Share by Type (2014-2019)
Table Global Acute Coronary Syndrome (ACS) Market Size by Application (2014-2019) (Million US$)
Table Global Acute Coronary Syndrome (ACS) Market Size Share by Application (2014-2019)
Figure Global Acute Coronary Syndrome (ACS) Market Size Market Share by Application (2014-2019)
Figure Global Acute Coronary Syndrome (ACS) Revenue Market Share by Application in 2018
Figure United States Acute Coronary Syndrome (ACS) Market Size 2014-2019 (Million US$)
Table United States Key Players Acute Coronary Syndrome (ACS) Revenue (2018-2019) (Million US$)
Table United States Key Players Acute Coronary Syndrome (ACS) Market Share (2018-2019)
Table United States Acute Coronary Syndrome (ACS) Market Size by Type (2014-2019) (Million US$)
Table United States Acute Coronary Syndrome (ACS) Market Share by Type (2014-2019)
Table United States Acute Coronary Syndrome (ACS) Market Size by Application (2014-2019) (Million US$)
Table United States Acute Coronary Syndrome (ACS) Market Share by Application (2014-2019)
Figure Europe Acute Coronary Syndrome (ACS) Market Size 2014-2019 (Million US$)
Table Europe Key Players Acute Coronary Syndrome (ACS) Revenue (2018-2019) (Million US$)
Table Europe Key Players Acute Coronary Syndrome (ACS) Market Share (2018-2019)
Table Europe Acute Coronary Syndrome (ACS) Market Size by Type (2014-2019) (Million US$)
Table Europe Acute Coronary Syndrome (ACS) Market Share by Type (2014-2019)
Table Europe Acute Coronary Syndrome (ACS) Market Size by Application (2014-2019) (Million US$)
Table Europe Acute Coronary Syndrome (ACS) Market Share by Application (2014-2019)
Figure China Acute Coronary Syndrome (ACS) Market Size 2014-2019 (Million US$)
Table China Key Players Acute Coronary Syndrome (ACS) Revenue (2018-2019) (Million US$)
Table China Key Players Acute Coronary Syndrome (ACS) Market Share (2018-2019)
Table China Acute Coronary Syndrome (ACS) Market Size by Type (2014-20189) (Million US$)
Table China Acute Coronary Syndrome (ACS) Market Share by Type (2014-2019)
Table China Acute Coronary Syndrome (ACS) Market Size by Application (2014-2019) (Million US$)
Table China Acute Coronary Syndrome (ACS) Market Share by Application (2014-2019)
Figure Japan Acute Coronary Syndrome (ACS) Market Size 2014-2019 (Million US$)
Table Japan Key Players Acute Coronary Syndrome (ACS) Revenue (2018-2019) (Million US$)
Table Japan Key Players Acute Coronary Syndrome (ACS) Market Share (2018-2019)
Table Japan Acute Coronary Syndrome (ACS) Market Size by Type (2014-2019) (Million US$)
Table Japan Acute Coronary Syndrome (ACS) Market Share by Type (2014-2019)
Table Japan Acute Coronary Syndrome (ACS) Market Size by Application (2014-2019) (Million US$)
Table Japan Acute Coronary Syndrome (ACS) Market Share by Application (2014-2019)
Figure Southeast Asia Acute Coronary Syndrome (ACS) Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Acute Coronary Syndrome (ACS) Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Acute Coronary Syndrome (ACS) Market Share (2018-2019)
Table Southeast Asia Acute Coronary Syndrome (ACS) Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Acute Coronary Syndrome (ACS) Market Share by Type (2014-2019)
Table Southeast Asia Acute Coronary Syndrome (ACS) Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Acute Coronary Syndrome (ACS) Market Share by Application (2014-2019)
Figure India Acute Coronary Syndrome (ACS) Market Size 2014-2019 (Million US$)
Table India Key Players Acute Coronary Syndrome (ACS) Revenue (2018-2019) (Million US$)
Table India Key Players Acute Coronary Syndrome (ACS) Market Share (2018-2019)
Table India Acute Coronary Syndrome (ACS) Market Size by Type (2014-2019) (Million US$)
Table India Acute Coronary Syndrome (ACS) Market Share by Type (2014-2019)
Table India Acute Coronary Syndrome (ACS) Market Size by Application (2014-2019) (Million US$)
Table India Acute Coronary Syndrome (ACS) Market Share by Application (2014-2019)
Figure Central & South America Acute Coronary Syndrome (ACS) Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Acute Coronary Syndrome (ACS) Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Acute Coronary Syndrome (ACS) Market Share (2018-2019)
Table Central & South America Acute Coronary Syndrome (ACS) Market Size by Type (2014-2019) (Million US$)
Table Central & South America Acute Coronary Syndrome (ACS) Market Share by Type (2014-2019)
Table Central & South America Acute Coronary Syndrome (ACS) Market Size by Application (2014-2019) (Million US$)
Table Central & South America Acute Coronary Syndrome (ACS) Market Share by Application (2014-2019)
Table Dexa Medica Company Details
Table Dexa Medica Revenue in Acute Coronary Syndrome (ACS) Business (2014-2019) (Million US$)
Figure Dexa Medica Revenue Growth Rate in Acute Coronary Syndrome (ACS) Business (2014-2019)
Table Dexa Medica Recent Development
Table GlaxoSmithKline Company Details
Table GlaxoSmithKline Revenue in Acute Coronary Syndrome (ACS) Business (2014-2019)(Million US$)
Figure GlaxoSmithKline Revenue Growth Rate in Acute Coronary Syndrome (ACS) Business (2014-2019)
Table GlaxoSmithKline Recent Development
Table Novartis Company Details
Table Novartis Revenue in Acute Coronary Syndrome (ACS) Business (2014-2019)(Million US$)
Figure Novartis Revenue Growth Rate in Acute Coronary Syndrome (ACS) Business (2014-2019)
Table Novartis Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Acute Coronary Syndrome (ACS) Business (2014-2019)(Million US$)
Figure Pfizer Revenue Growth Rate in Acute Coronary Syndrome (ACS) Business (2014-2019)
Table Pfizer Recent Development
Table Sanofi Company Details
Table Sanofi Revenue in Acute Coronary Syndrome (ACS) Business (2014-2019)(Million US$)
Figure Sanofi Revenue Growth Rate in Acute Coronary Syndrome (ACS) Business (2014-2019)
Table Sanofi Recent Development
Table Serum Institute of India Company Details
Table Serum Institute of India Revenue in Acute Coronary Syndrome (ACS) Business (2014-2019)(Million US$)
Figure Serum Institute of India Revenue Growth Rate in Acute Coronary Syndrome (ACS) Business (2014-2019)
Table Serum Institute of India Recent Development
Table Biogen Inc Company Details
Table Biogen Inc Revenue in Acute Coronary Syndrome (ACS) Business (2014-2019)(Million US$)
Figure Biogen Inc Revenue Growth Rate in Acute Coronary Syndrome (ACS) Business (2014-2019)
Table Biogen Inc Recent Development
Table Eli Lilly and Company Company Details
Table Eli Lilly and Company Revenue in Acute Coronary Syndrome (ACS) Business (2014-2019)(Million US$)
Figure Eli Lilly and Company Revenue Growth Rate in Acute Coronary Syndrome (ACS) Business (2014-2019)
Table Eli Lilly and Company Recent Development
Table Global Acute Coronary Syndrome (ACS) Market Size by Regions (Million US$) 2019-2025
Figure Global Acute Coronary Syndrome (ACS) Market Size Share by Regions (2019-2025)
Figure Global Acute Coronary Syndrome (ACS) Market Size Share by Regions in 2025
Figure United States Acute Coronary Syndrome (ACS) Market Size Forecast (2019-2025)(Million USD)
Figure Europe Acute Coronary Syndrome (ACS) Market Size Forecast (2019-2025)(Million USD)
Figure China Acute Coronary Syndrome (ACS) Market Size Forecast (2019-2025)(Million USD)
Figure Japan Acute Coronary Syndrome (ACS) Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Acute Coronary Syndrome (ACS) Market Size Forecast (2019-2025)(Million USD)
Figure India Acute Coronary Syndrome (ACS) Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Acute Coronary Syndrome (ACS) Market Size Forecast (2019-2025)(Million USD)
Table Global Acute Coronary Syndrome (ACS) Market Size by Product (2019-2025) (Million US$)
Figure Global Acute Coronary Syndrome (ACS) Market Size by Product (2019-2025)
Figure Global Acute Coronary Syndrome (ACS) Market Size by Product in 2025
Table Global Acute Coronary Syndrome (ACS) Market Size by Application (2019-2025) (Million US$)
Figure Global Acute Coronary Syndrome (ACS) Market Size by Application (2019-2025)
Figure Global Acute Coronary Syndrome (ACS) Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

---